Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
generic:
mechanism:
None (86) ·
70–90% (oral) (1) ·
~0.3% (oral; extensive first-pass via CYP3A4 and P-glycoprotein-mediated efflux at the intestinal and blood-brain barriers limit systemic and CNS exposure at therapeutic doses)'"`UNIQ--ref-00000FD3-QINU`"' (1) ·
~50% (variable, CYP2D6-dependent for analgesic effect). (1)
None (86) ·
Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) ·
Generally considered acceptable when needed.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Not established (1)
Showing below up to 89 results in range #1 to #89.
1
2
- 25B-NBOH
- 25B-NBOMe
- 25C-NBOH
- 25C-NBOMe
- 25I-NBOH
- 25I-NBOMe
- 25N-NBOMe
- 2C-B-FLY
- 2C-C
- 2C-D
- 2C-E
- 2C-I
- 2C-P
- 2C-T-2
- 2C-T-7
4
5
A
B
C
D
E
F
H
L
M
N
O
P
- Papaverine
- Pentazocine
- Peyote
- Pharmacopedia:Pharmacogenomics sandbox/Codeine
- PRO-LAD
- Proscaline
- Psilocin
- Psilocybin mushrooms


